Log in to save to my catalogue

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023...

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_867047

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

Publication information

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

ObjectiveNew modes of action and more data on the efficacy and safety of existing drugs in psoriatic arthritis (PsA) required an update of the EULAR 2019 recommendations for the pharmacological treatment of PsA.MethodsFollowing EULAR standardised operating procedures, the process included a systematic literature review and a consensus meeting of 36...

Alternative Titles

Full title

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_867047

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_867047

Other Identifiers

ISSN

0003-4967,1468-2060

E-ISSN

1468-2060

DOI

10.1136/ard-2024-225531